GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Institutional Ownership

Noxopharm (ASX:NOX) Institutional Ownership : 0.00% (As of May. 15, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Noxopharm's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Noxopharm's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Noxopharm's Float Percentage Of Total Shares Outstanding is 0.00%.


Noxopharm Institutional Ownership Historical Data

The historical data trend for Noxopharm's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm Institutional Ownership Chart

Noxopharm Historical Data

The historical data trend for Noxopharm can be seen below:

2022-09-30 2022-10-31 2022-11-30 2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30
Institutional Ownership 1.03 1.06 0.99 0.95 1.02 1.03 1.03 1.05 1.06 0.77

Noxopharm Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Noxopharm (ASX:NOX) Business Description

Traded in Other Exchanges
Address
60 Linksley Ave, Glenhaven, NSW, AUS, 2156
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines